Guided Therapy Systems has launched its intense therapeutic ultrasound (ITU) Actisound device in the U.K. and Europe following CE Mark approval.

Actisound acts like an invisible scalpel, working beneath the surface of the skin to precisely deliver small thermal ablations to tendons, ligaments, and other soft tissue to stimulate collagen growth and the regeneration of connective tissue.

Unlike other energy sources such as laser, microwave and radio frequency, ultrasound is the only energy source that can penetrate safely through intervening tissue and be focused to a specific point and shape within the body, according to a company statement. This allows physicians the ability to deliver treatments directly at the point of injury, up to depths of 15 mm, without surgery.

Actisound is the only non-invasive, ablative treatment for pain relief associated with the repair of musculoskeletal injuries available to medical professionals, the statement added.

“CE mark is the result of many years of rigorous research, development and clinical testing. Starting today, clinicians can offer a better, safer, and more efficient healing process,” said Guided Therapy Systems’ founder and CEO, Michael Slayton in the statement. “Actisound’s intense therapeutic ultrasound represents a completely new treatment option that wasn’t before available to chronic patients, and it’s the only option (outside of conservative therapies) that doesn’t include painful or costly procedures.”

Actisound was developed and manufactured for Guided Therapy Systems by Ardent Sound.